• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>RailAmerica

RailAmerica

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. AstraZeneca and Moderna Announce Filing of First Clinical Trial Application in Messenger RNA Therapeutics™ Collaboration

    AstraZeneca and Moderna Announce Filing of First Clinical Trial Application in Messenger RNA Therapeutics™ Collaboration

  2. BIOCAD: Advanced rheumatoid arthritis medicine developed in Russia

    BIOCAD: Advanced rheumatoid arthritis medicine developed in Russia

  3. Robbins Arroyo LLP: Acquisition of Ardelyx, Inc. (ARDX) by Multiple Acquirers (Private) May Not Be in Shareholders' Best Interests

    Robbins Arroyo LLP: Acquisition of Ardelyx, Inc. (ARDX) by Multiple Acquirers (Private) May Not Be in Shareholders' Best Interests

  4. Technavio Announces Top Three Emerging Trends Impacting the Global Baseball Equipment Market Through 2020

    Technavio Announces Top Three Emerging Trends Impacting the Global Baseball Equipment Market Through 2020

  5. Our Take on the Fourth Quarter

    A look back at the winners and losers of the final quarter of a tumultuous year.

  6. Parsing the Industrials Landscape in ETFs

    There is a small number of high-quality industrials-sector ETFs from which to choose.

  7. List of Rail Stocks: A Steady, Boring But Highly Profitable Industry

    The author does not own any of the stocks or funds mentioned above.

  8. In Search of Tax Efficiency

    Most mutual fund managers do not focus on aftertax performance, but astute investors may be able to improve their aftertax returns. 

  9. Breaking the 4% Rule

    Opinions and statements of financial market trends that are based on current market conditions constitute our judgment and are subject to change without notice. We believe the information provided here is reliable but should not be assumed to be accurate or complete. The views and strategies ...

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.